Zealand Pharma obesity drug continues to phase II
![Photo: Zealand Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14108569.ece/ALTERNATES/schema-16_9/doc7lbugwc125ktwnj8f12.jpg)
Novo Nordisk and Eli Lilly are battling it out on the billion-dollar obesity market, and Zealand Pharma wants in.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Zealand Pharma CEO believes in firm's obesity efforts
For subscribers
Zealand Pharma issues almost USD 40m in shares
For subscribers